Blog

Thoughts from Datavant leaders on the evolving health data landscape

Our engineering and data science team keeps a separate blog here.

The Golden Age of Middleware: Why Visa Has Always Been a Great Middleware Company [And Why Buying Plaid Makes Sense]

Author’s Note: I am a huge fan of middleware companies. Datavant is a middleware company connecting health data; my last startup, LiveRamp (now NYSE:RAMP), is the largest marketing middleware company; and I am an investor in a number of middleware companies across industries. The Visa/Plaid combination is a great example of what…

Introducing Datavant for Clinical Trials

We are excited today to announce Datavant for Clinical Trials, a solution that makes it easy for sponsors, CROs, and regulators to confidently bridge traditional clinical trial data with real-world data. This morning, we announced a multi-year strategic partnership with Parexel to roll out this connectivity solution across all of…

Introducing Datavant for Clinical Trials

We are excited today to announce Datavant for Clinical Trials, a solution that makes it easy for sponsors, CROs, and regulators to confidently bridge traditional clinical trial data with real-world data. This morning, we announced a multi-year strategic partnership with Parexel to roll out this connectivity solution across all of…

Advancing the Frontier of Privacy-Preserving Technology in Healthcare

Datavant’s mission is to connect the world’s health data, and make it accessible for valuable research and analytics. The traditional approach of aggregating data creates a direct tradeoff between individual privacy and analytical capability. With health data, this isn’t good enough. The stakes are high — data-driven decisions can save lives, just…

Advancing the Frontier of Privacy-Preserving Technology in Healthcare

Datavant’s mission is to connect the world’s health data, and make it accessible for valuable research and analytics. The traditional approach of aggregating data creates a direct tradeoff between individual privacy and analytical capability. With health data, this isn’t good enough. The stakes are high — data-driven decisions can save lives, just…
1qlZEsRqFjGjcn-j974TjBQ.png

An Overview of Approaches to Privacy-Preserving Data Sharing

This is a non-technical survey of approaches to how “deidentification” happens in healthcare, pros and cons of a variety of approaches, and an overview of where privacy-preserving technology is headed. Thanks to privacy technology thought leaders Abel Kho, Andrei Lapets, Dan Barth-Jones, Patrick Baier, and Ian Coe (as well as…